Invivyd, Inc. - Common Stock, $0.0001 par value per share (IVVD)

CUSIP: 00534A102

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 7 signals
Share change
+16,578,311
Put/Call ratio
2.8%
SEC-reported price per share
$4.44
Number of holders
85
Value change
+$73,496,983
Number of buys
56
Open additional details 1 more signal available
Number of sells
23
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
304,892,029

Security key

00534A102

Report period

Q1 2024

Institutions

85

Top holders

10

Ownership snapshot

Top reported holders of IVVD - Invivyd, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
MAVERICK CAPITAL LTD
Disclosed value leader
MAVERICK CAPITAL LTD
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F 3/4/5 Lead comparable stake: 3.1% Showing 1-6 of 15 holder rows.

Quick read

MAVERICK CAPITAL LTD leads the comparable SEC ownership view at 3.1%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MAVERICK CAPITAL LTD's linked filing trail.
Comparable ownership Top 5
MAVERICK CAPITAL LTD 3.1%
M28 Capital Management LP 3%
FMR LLC 2.8%
Alphabet Inc. 1.9%
ORBIMED ADVISORS LLC 1.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
MAVERICK CAPITAL LTD
13F
Company
13F
3.1%
$36,815,159
9,343,949 shares
31 Dec 2023
M28 Capital Management LP
13F
Company
13F
3%
$36,438,105
9,248,250 shares
31 Dec 2023
FMR LLC
13F
Company
13F
2.8%
$33,143,158
8,411,969 shares
31 Dec 2023
Alphabet Inc.
13F
Company
13F
1.9%
$22,382,292
5,680,785 shares
31 Dec 2023
ORBIMED ADVISORS LLC
13F
Company
13F
1.4%
$16,262,606
4,127,565 shares
31 Dec 2023
Slate Path Capital LP
13F
Company
13F
1.2%
$14,715,900
3,735,000 shares
31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
85
Shares
72,368,404
Rows available
85
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders
59
Q1 2024 holders
85
Holder diff
26
Investor Q4 2023 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2023 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .